Free Trial

Axsome Therapeutics (AXSM) Insider Trading & Ownership

Axsome Therapeutics logo
$219.82 -2.81 (-1.26%)
Closing price 03:59 PM Eastern
Extended Trading
$220.09 +0.27 (+0.12%)
As of 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Axsome Therapeutics (NASDAQ:AXSM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
20.60%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$200.47K
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$124.07M
Get AXSM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Axsome Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AXSM Insider Buying and Selling by Quarter

Axsome Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/5/2026Sell233$228.18$53,165.94  
5/4/2026Sell4,517$227.94$1,029,604.98  
4/22/2026
Ari Maizel
Insider
Sell7,500$182.42$1,368,150.00  
2/26/2026
Mark Coleman
Mark Coleman
Director
Sell25,000$161.11$4,027,750.00  
2/26/2026Sell35,378$161.88$5,726,990.64  
2/2/2026Sell32,410$185.60$6,015,296.00  
1/22/2026Sell12,000$187.92$2,255,040.00  
1/21/2026
Ari Maizel
Insider
Sell7,500$184.44$1,383,300.00  
1/7/2026Sell31,261$170.38$5,326,249.18  
1/6/2026Sell29,450$172.33$5,075,118.50  
1/5/2026Sell78,703$171.28$13,480,249.84  
12/31/2025
Mark E Saad
Mark E Saad
Director
Sell37,577$165.18$6,206,968.86  
12/4/2025Sell10,558$148.18$1,564,484.44  
12/3/2025Sell20,163$146.94$2,962,751.22  
12/2/2025Sell49,252$144.59$7,121,346.68  
11/5/2025Sell21,775$134.49$2,928,519.75  
11/4/2025Sell50,459$133.79$6,750,909.61  
11/3/2025Sell91,705$132.34$12,136,239.70  
10/8/2025Sell12,774$118.84$1,518,062.16  
10/7/2025Sell13,390$118.77$1,590,330.30  
10/6/2025Sell19,220$120.17$2,309,667.40  
9/22/2025Sell10,000$115.96$1,159,600.00  
9/16/2025Sell19,719$114.19$2,251,712.61  
9/16/2025Sell45,783$114.48$5,241,237.84  
9/15/2025Sell15,254$117.37$1,790,361.98  
9/12/2025Sell27,907$118.96$3,319,816.72  
9/8/2025
Mark Coleman
Mark Coleman
Director
Buy1,575$127.28$200,466.00  
9/5/2025
Mark E Saad
Mark E Saad
Director
Sell9,127$125.07$1,141,513.89  
9/2/2025
Roger Jeffs
Roger Jeffs
Director
Sell13,464$123.68$1,665,227.52  
8/28/2025
Roger Jeffs
Roger Jeffs
Director
Sell20,000$121.60$2,432,000.00  
8/26/2025
Roger Jeffs
Roger Jeffs
Director
Sell20,000$120.03$2,400,600.00  
8/22/2025
Roger Jeffs
Roger Jeffs
Director
Sell16,694$120.08$2,004,615.52  
6/23/2025
Hunter R. Murdock
Hunter R. Murdock
General Counsel
Sell6,014$100.12$602,121.68  
6/20/2025
Hunter R. Murdock
Hunter R. Murdock
General Counsel
Sell7,500$102.47$768,525.00  
6/17/2025
Hunter R. Murdock
Hunter R. Murdock
General Counsel
Sell7,500$100.26$751,950.00  
6/9/2025Sell25,000$110.44$2,761,000.00  
5/28/2025Sell20,000$103.45$2,069,000.00  
5/27/2025
Mark Coleman
Mark Coleman
Director
Sell3,750$105.47$395,512.50  
5/27/2025Sell20,673$104.66$2,163,636.18  
5/20/2025
Mark Coleman
Mark Coleman
Director
Sell3,000$107.49$322,470.00  
(Data available from 1/1/2013 forward)

AXSM Insider Trading Activity - Frequently Asked Questions

20.60% of Axsome Therapeutics stock is owned by insiders. Learn more on AXSM's insider holdings.

The following insider purchased AXSM shares in the last 24 months: Mark Coleman ($200,466.00).

Insiders have purchased a total of 1,575 AXSM shares in the last 24 months for a total of $200,466.00 bought.

The following insiders have sold AXSM shares in the last 24 months: Ari Maizel ($2,751,450.00), Herriot Tabuteau ($76,141,116.09), Hunter R. Murdock ($2,122,596.68), Mark Coleman ($5,140,509.79), Mark E Saad ($8,354,353.71), Mark L Jacobson ($24,814,515.82), Nick Pizzie ($2,648,250.00), and Roger Jeffs ($8,502,443.04).

Insiders have sold a total of 957,124 Axsome Therapeutics shares in the last 24 months for a total of $130,475,235.13 sold.



This page (NASDAQ:AXSM) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners